06:48 AM EDT, 10/22/2024 (MT Newswires) -- Mangoceuticals ( MGRX ) said late Monday it "strongly refutes" Eli Lilly's ( LLY ) claims that the company "improperly" imitated its weight-loss Zepbound and Mounjaro medicines.

"MangoRx strongly refutes any and all claims made by Eli Lilly ( LLY ) regarding the sale of compounded tirzepatide," the company added.

Eli Lilly ( LLY ) filed lawsuits against medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its weight-loss drug Zepbound.

Eli Lilly ( LLY ) did not immediately respond to MT Newswires' request for comment.